| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
We re committed to breakthrough firsts in womens sexual health. Novel ideas fuel our entrepreneurial passion. At Sprout, we celebrate ownership, boldness, quirkiness, learning, family and appreciation. They are central to what we stand for and what we re trying to collectively accomplish.
Established 25 years ago, Coordinated Health is a privately held, physician-owned, specialized hospital network delivering an accessible, affordable and fully integrated continuum of care in eastern Pennsylvania and western New Jersey. Our more than 70 physicians and our full 1,200-member team focus on many healthcare specialties. Coordinated Health is the only hospital in Lehigh Valley to achieve the Top Performer rating from The Joint Commission for three consecutive years. The company has repeatedly earned the highest patient satisfaction scores from the Centers for Medicare and Medicaid Services and the lowest infection rates from one of the country’s leading consumer advocacy groups. In 2014, Coordinated Health was the only hospital in its area to receive the annual Healthgrades Patient Safety Excellence Award.
Comprehensive Alcoholism Treatment Program is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As one of the world`s premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and the biomedical research agenda around the world.